Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT02518620
Status:
COMPLETED
Last Update Posted:
2019-07-30
First Post:
2015-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis
Sponsor:
Ablynx, a Sanofi company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-06
First Submit QC Date:
None
Study First Post Date:
2015-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-23
Results First Submit QC Date:
None
Results First Post Date:
2019-07-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-19
Last Update Post Date:
2019-07-30
Last Update Post Date Type:
ACTUAL